Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 1/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.36 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.36 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.36 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | CPB2 | Q96IY4 | 8/20 | 0.32 |
| ▸ | BCHE | P06276 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | RYR2 | Q92736 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31034900 | 0.91 | FAAH (0.43) | FAAHADRA2AADRA2BADRA2CADRA1B | |
| SCHEMBL31034887 | 0.90 | POLB (0.41) | FAAHADRA2AADRA2BADRA2CADRA1B | |
| SCHEMBL31034838 | 0.86 | FAAH (0.42) | FAAHHRH3 | |
| SCHEMBL31034854 | 0.86 | ADRA2A (0.37) | FAAHADRA2AADRA2BADRA2CADRA1B | |
| SCHEMBL31034827 | 0.80 | MEN1 (0.38) | ADRA2AADRA2BADRA2CADRA1BHRH3 | |
| SCHEMBL31034923 | 0.78 | POLB (0.38) | FAAHPOLBATMBCHESLC6A2 | |
| SCHEMBL9325910 | 0.76 | ADRA2A (0.43) | ADRA2AADRA2BADRA2CADRA1BHRH3 | |
| SCHEMBL31034919 | 0.75 | ADRA2A (0.39) | ADRA2AADRA2BADRA2CADRA1BHRH3 | |
| SCHEMBL31034909 | 0.75 | ADRA2A (0.36) | ADRA2AADRA2BADRA2CADRA1BHRH3 | |
| SCHEMBL9325735 | 0.74 | ADRA2A (0.42) | ADRA2AADRA2BADRA2CADRA1BTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4658639-A1 | N,N-DIALKYL-4-(2-ETHYLINDAN-2-YL)-1H-IMIDAZOLE-1-CARBOXAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | Univerza V Ljubljani (SI) | 2025-12-10 | — | — | EP | claimed |
| WO-2024160908-A1 | N,N-DIALKYL-4-(2-ETHYLINDAN-2-YL)-1H-IMIDAZOLE-1-CARBOXAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | UNIVERZA V LJUBLJANI (SI) | 2024-08-08 | — | — | WO | claimed |
| EP-4658639-A1 | N,N-DIALKYL-4-(2-ETHYLINDAN-2-YL)-1H-IMIDAZOLE-1-CARBOXAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | Univerza V Ljubljani (SI) | 2025-12-10 | — | — | EP | disclosed |
| WO-2024160908-A1 | N,N-DIALKYL-4-(2-ETHYLINDAN-2-YL)-1H-IMIDAZOLE-1-CARBOXAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | UNIVERZA V LJUBLJANI (SI) | 2024-08-08 | — | — | WO | disclosed |